Chemophase Trademark Details

Chemophase was registered on Tuesday, February 21, 2006 and is currently owned by Halozyme Therapeutics, Inc. under the registration number 3061135 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 11 years ago on Friday, September 28, 2012, according to the United State Patent & Trademark Office
Word Mark Chemophase
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Halozyme Therapeutics, Inc. of San Diego, CA

View all trademarks for Halozyme Therapeutics, Inc.
Other Trademarks for Halozyme Therapeutics, Inc.
Serial Number 78404391
Registration Number 3061135
Status Date Friday, September 28, 2012
Filing Date Friday, September 28, 2012
Registration Date Tuesday, February 21, 2006
Attorney Rosemary S. Tarlton

Correspondent

Rosemary S. Tarlton
Morrison & Foerster LLP
425 Market Street
San Francisco CA 94105-2482

Case File Statements

Goods & Services High dose intravenous formulation of recombinant human hyaluronidase for use as a chemotherapy adjuvant
Pseudo Mark Chemotherapy Phase

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, September 28, 2012
First Use Anywhere Thursday, October 27, 2005
First Use In Commerce Thursday, October 27, 2005
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.